Delivery Order SPE2DB25D3012-SPE2DB25FWZAY
Award Date 8/6/25
Potential Completion Date 8/7/25
Potential Value $1.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,271.67 to AmerisourceBergen Drug Corp for Wixela 250-50 inhaler (60-count), a combination pharmaceutical product. The contract, executed on September 11, 2025, with an ultimate completion date of September 12, 2025, operates under firm fixed-price terms with no set-aside designation, indicating competitive award. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,351.08 to AmerisourceBergen Drug Corp for WIXELA 250-50 inhaler units (60-count) on April 25, 2025, with an ultimate completion date of April 28, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,378.26 to AmerisourceBergen Drug Corp for WIXELA 500-50 inhaler units (60-count) on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. The award was made without a set-aside designation, and performance will take place at the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $1,030.31 to AmerisourceBergen Drug Corp for WIXELA 250-50 inhaler units (60-count). The contract, which became effective on May 20, 2025, with completion by May 21, 2025, is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency Medical Supply Chain awarded a $1,548.77 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the pharmaceutical product Wixela 250-50 inhaler with 60 doses. The contract represents a non-competitive, non-set-aside delivery order with an ultimate completion date of September 3, 2025, and is to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order valued at $2,374.92 to AmerisourceBergen Drug Corp for WIXELA 250-50 inhalers (60-count), with an ultimate completion date of August 29, 2025. This non-set-aside, firm fixed price delivery order was competitively awarded and represents a direct fulfillment of pharmaceutical supply needs through AmerisourceBergen's existing contract vehicle. The product will be delivered to the vendor's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Wixela 500-50 inhaler, 60-count units, with a ceiling value of $2,009.59. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award practices. The order is scheduled for ultimate completion by October 9, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a $1,564.83 delivery order to AmerisourceBergen Drug Corp for WIXELA 500-50 inhaler products on June 2, 2025, with an ultimate completion date of June 3, 2025. This contract was issued under firm fixed pricing with no set-aside designation, indicating competitive award conditions. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. As a child delivery order, this award is...
- The Defense Logistics Agency awarded a delivery order valued at $2,155.90 to AmerisourceBergen Drug Corp for WIXELA 250-50 inhalers (60-count units) on September 19, 2025, with completion scheduled for September 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award to the prime contractor at its Conshohocken, Pennsylvania location. The order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,483.86 to AmerisourceBergen Drug Corp for WIXELA 100-50 inhalation powder, a combination asthma and COPD medication. Issued on August 5, 2025, with an ultimate completion date of August 6, 2025, this firm fixed-price delivery order was competitively awarded without set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...